Invesco Ltd. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$2,996,035
-53.4%
185,513
+19.6%
0.00%
-50.0%
Q2 2023$6,435,698
-29.5%
155,077
+2.2%
0.00%
-33.3%
Q1 2023$9,126,367
-17.2%
151,752
+1.0%
0.00%0.0%
Q4 2022$11,018,710
+76.6%
150,221
+82.9%
0.00%
+50.0%
Q3 2022$6,240,000
+4.1%
82,134
-4.8%
0.00%0.0%
Q2 2022$5,994,000
+2.9%
86,255
+22.6%
0.00%
+100.0%
Q1 2022$5,826,000
+28.6%
70,328
+16.5%
0.00%0.0%
Q4 2021$4,531,000
-73.6%
60,342
-59.1%
0.00%
-75.0%
Q3 2021$17,136,000
-68.4%
147,502
-39.7%
0.00%
-69.2%
Q2 2021$54,289,000
+228.8%
244,744
+95.9%
0.01%
+225.0%
Q1 2021$16,512,000
+45.2%
124,915
+90.0%
0.00%
+33.3%
Q4 2020$11,374,000
+524.9%
65,730
+302.0%
0.00%
+200.0%
Q3 2020$1,820,000
+13.0%
16,350
-39.8%
0.00%0.0%
Q2 2020$1,611,000
-96.5%
27,179
-96.1%
0.00%
-95.0%
Q1 2020$46,509,000
-42.6%
690,657
-28.1%
0.02%
-20.0%
Q4 2019$81,002,000
+92.2%
961,222
+70.5%
0.02%
+127.3%
Q3 2019$42,150,000
+11.2%
563,658
-6.0%
0.01%
+10.0%
Q2 2019$37,903,000
+109.2%
599,437
+59.4%
0.01%
+66.7%
Q1 2019$18,116,000
+157.3%
376,085
+78.9%
0.01%
+100.0%
Q4 2018$7,040,000
-58.9%
210,270
-35.7%
0.00%
-40.0%
Q3 2018$17,148,000
+460.2%
327,257
+234.6%
0.01%
+400.0%
Q2 2018$3,061,000
+65.5%
97,810
+15.3%
0.00%0.0%
Q1 2018$1,849,000
-63.1%
84,795
-65.8%
0.00%
-50.0%
Q4 2017$5,008,000
+49.5%
247,924
+47.0%
0.00%
+100.0%
Q3 2017$3,349,000168,7000.00%
Other shareholders
NOVOCURE LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders